Coronary Artery Bypass Graft Devices Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

CABG remains one of the most frequently performed cardiac surgical procedures worldwide, serving patients with severe coronary artery disease. The devices market covers a range of products including cardiopulmonary bypass machines, endoscopic vessel harvesting systems, arterial and venous grafts, and surgical instruments used during both on-pump and off-pump procedures.

• •Market valued at approximately $3.1 billion globally in 2025 with a projected 6.4% annual growth rate
• •Key product categories include bypass pumps, harvest devices, conduits, and supporting surgical instruments
• •Demand is fueled by rising coronary artery disease burden and growing preference for surgical revascularization over percutaneous interventions in complex cases

The market expansion is primarily propelled by the global rise in cardiovascular disease, particularly coronary artery disease linked to sedentary lifestyles, poor diet, and increasing diabetes prevalence. Aging demographics, especially in developed nations, create a larger patient pool requiring surgical intervention as arterial disease risk increases with age.

• •Advancements in minimally invasive and robotic-assisted CABG techniques are broadening patient eligibility and surgical adoption
• •Growing healthcare expenditure and improved cardiac surgery infrastructure in emerging economies are expanding market access
• •Hybrid procedures combining CABG with transcatheter approaches are driving demand for integrated device solutions

The market is segmented by product type, graft type, procedure type, and end user, with hospitals and cardiac surgery centers representing the primary end-user segment. North America currently holds the largest market share due to advanced healthcare infrastructure, high procedure volumes, and favorable reimbursement environments.

• •Asia-Pacific is expected to be the fastest-growing regional market, driven by improving medical facilities and rising disease prevalence in China, India, and Southeast Asia
• •Europe maintains a significant share supported by established healthcare systems and ongoing procedural demand
• •On-pump procedures dominate currently, though off-pump and minimally invasive techniques are gaining traction

What are the recent trends and outlook?

The future of the CABG devices market is being shaped by digital integration, enhanced graft materials, and the continued shift toward less invasive surgical approaches. Robotic-assisted CABG and hybrid revascularization strategies are expected to drive procedural growth and influence device design requirements.

• •Digital technologies including surgical navigation systems and intraoperative imaging are increasingly integrated into CABG workflows
• •Biological and synthetic graft materials continue to advance, with research focused on improving long-term patency and reducing infection risk
• •The market is expected to reach substantially higher valuations by the early 2030s, supported by cumulative disease burden and technology adoption trends